Twist Bioscience Corp Asset Resilience Ratio
Twist Bioscience Corp asset resilience ratio. Twist Bioscience Corp (TWST) has an Asset Resilience Ratio of 7.35% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See operational self-sufficiency of Twist Bioscience Corp to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Twist Bioscience Corp (2016–2025)
Asset resilience ratio of Twist Bioscience Corp from 2016 to 2025. This chart shows how Twist Bioscience Corp's Asset Resilience Ratio has changed over time. Read Twist Bioscience Corp (TWST) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Twist Bioscience Corp's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Twist Bioscience Corp.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $49.40 Million | 7.35% |
| Total Liquid Assets | $49.40 Million | 7.35% |
Asset Resilience Insights
- Limited Liquidity: Twist Bioscience Corp maintains only 7.35% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Twist Bioscience Corp Industry Peers by Asset Resilience Ratio
Compare Twist Bioscience Corp's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Hyloris Developmentsen Sa
BR:HYL |
Biotechnology | 1.36% |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
Oruka Therapeutics, Inc.
NASDAQ:ORKA |
Biotechnology | 53.11% |
|
Gempharmatech Co. Ltd. A
SHG:688046 |
Biotechnology | 23.95% |
|
Vor Biopharma Inc
NASDAQ:VOR |
Biotechnology | 74.48% |
|
Inventiva S.A
PA:IVA |
Biotechnology | 52.73% |
|
Sunmax Biotechnology Co Ltd
TWO:4728 |
Biotechnology | 10.53% |
|
Guangdong VTR Bio-Tech Co Ltd
SHE:300381 |
Biotechnology | 4.98% |
Twist Bioscience Corp Asset Resilience Ratio by Year (2016–2025)
Twist Bioscience Corp asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Twist Bioscience Corp.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-09-30 | 7.69% | $49.38 Million | $641.86 Million | -0.46pp |
| 2024-09-30 | 8.15% | $50.08 Million | $614.32 Million | +1.72pp |
| 2023-09-30 | 6.43% | $49.94 Million | $776.40 Million | -6.70pp |
| 2022-09-30 | 13.14% | $126.28 Million | $961.38 Million | +11.42pp |
| 2021-09-30 | 1.71% | $12.03 Million | $702.10 Million | -47.51pp |
| 2020-09-30 | 49.22% | $196.34 Million | $398.88 Million | +0.36pp |
| 2019-09-30 | 48.86% | $91.37 Million | $186.99 Million | -- |
| 2018-09-30 | 0.00% | $0.00 | $115.79 Million | -- |
| 2017-09-30 | 36.16% | $30.98 Million | $85.66 Million | +0.43pp |
| 2016-09-30 | 35.73% | $27.32 Million | $76.46 Million | -- |
About Twist Bioscience Corp
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo … Read more